Dr. Martens
Dr. Martens lowers full year profit guidance
The iconic British brand has lowered its FY 23 profit outlook due to costs associated with resolving operational issues at its LA distribution centre, as well as a decline in wholesale revenue
Dr. Martens appoints non-executive director
The iconic British footwear brand has announced that Andrew Harrison will join the board of the company as an independent non-executive director, effective as of the 1st of May
Dr. Martens launches deadstock collection
The British label has launched the Made in England Deadstock collection, using high-quality surplus leathers from a range of tanneries, as part of the company’s waste reduction commitment
Dr. Martens posts third quarter results below expectations
The British label reported a third quarter revenue below expectations due to "slower than anticipated" DTC growth in America and major operational issues at the LA distribution centre
Dr. Martens warns on full year profit margins
Despite a strong performance in the first half, the British label is concerned with full year profits due to weaker consumer demand, higher investment in its DTC channel and a stronger US dollar
Dr. Martens launches trial resale scheme
The British footwear brand announced that it will partner up with Depop, a European online second-hand marketplace, in a trial programme to sell repaired and refurbished shoes
Dr. Martens posts strong fiscal 2022
The British footwear brand announced that it sold a record number of pairs (14.1 million) in fiscal 2022, which was translated into revenue growth of 18%, as compared to the prior fiscal year
Dr. Martens names new Global Creative Director
The position will be held by Darren McKoy, known as DMac, who served before as Global Category Product Director. He stated that he will continue honouring the brand’s legacy
Dr. Martens’ main shareholder sells part of its shares
The Luxembourg company IngreLux, owned by funds advised by the private equity firm Permira, has announced that it has sold 65 million of its ordinary shares, at the price of 4.73 euros
Dr. Martens posts revenue growth
The iconic footwear brand reported strong performance in the first half of fiscal 2022, driven by retail recovery and sustained e-commerce growth
Strong first quarter for Dr. Martens
Group revenue was up by 52% year on year. By channel, Dr. Martens saw recovery of its retail segment while ecommerce registered good growth against a very strong comparative and a strong wholesale performance. All regions saw good growth
Dr. Martens could launch IPO soon
The British-based footwear brand known for its iconic boots has reportedly appointed Goldman Sachs and Morgan Stanley to lead its initial public offering (IPO)
Dr. Martens sale rumors intensify
American-based investment firm Carlyle Group is reportedly in the race for British footwear brand Dr. Martens
Several bidders for sneaker brand Golden Goose
Permira and VF are amongst the list of interested. This follows Golden Goose owner Carlyle invitation for the submission of non-binding offers by mid-December
Permira wanting to sell Dr. Martens
Dr. Martens might change owners soon. According to several reports on the news, owner Permira is aiming to cash in taking advantage of the recent good results of the brand-
Footwear Consumer 2030
A study reflecting on the main global consumer trends and the key changes for the footwear industry.
-
World Footwear Public Calendar
Click here to subscribe an updated version of the calendar displaying the footwear trade shows.
-
-
-
-
-
Media Partners
Media Partners
-
La Conceria
Revista del Calzado
SERMA
Shoes Report